サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1319536

世界の生物学的原薬製造市場：考察と予測 (2029年まで)

Global Biological API Drug Manufacturing Market Insights, Forecast to 2029
出版日: | 発行: QYResearch | ページ情報: 英文 110 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
世界の生物学的原薬製造市場：考察と予測 (2029年まで)
出版日: 2023年08月02日
発行: QYResearch
ページ情報: 英文 110 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、生物学的原薬製造 (Biological API Drug Manufacturing) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 調査対象

  • 生物学的原薬製造の製品概要
  • 市場：タイプ別
    • 世界の生物学的原薬製造 市場規模：タイプ別, 2018 VS 2022 VS 2029
    • In-House manufacturing
    • Contract manufacturing
  • 市場：用途別
    • 世界の生物学的原薬製造 市場規模：用途別, 2018 VS 2022 VS 2029
    • Monoclonal Antibody (mAb) Therapies
    • Vaccines
    • Insulin Therapies
    • Interferon Therapies
    • Other
  • 前提条件と制限
  • 調査目的
  • 対象期間

第2章 世界の生物学的原薬製造の生産

  • 世界の生物学的原薬製造の生産能力 (2018-2029)
  • 世界の生物学的原薬製造の生産 地域別: 2018 VS 2022 VS 2029
  • 世界の生物学的原薬製造の生産 地域別
    • 世界の生物学的原薬製造の生産実績：地域別 (2018-2023)
    • 世界の生物学的原薬製造の生産予測：地域別 (2024-2029)
    • 世界の生物学的原薬製造の生産 市場 シェア 地域別 (2018-2029)
  • 北米
  • 欧州
  • 中国
  • 日本

第3章 レポート概要

  • 世界の生物学的原薬製造の収益 推定および予測 2018-2029
  • 世界の生物学的原薬製造の収益：地域別
    • 世界の生物学的原薬製造の収益：地域別: 2018 VS 2022 VS 2029
    • 世界の生物学的原薬製造の収益：地域別 (2018-2023)
    • 世界の生物学的原薬製造の収益：地域別 (2024-2029)
    • 世界の生物学的原薬製造の収益市場シェア 地域別 (2018-2029)
  • 世界の生物学的原薬製造売上予測・予想 2018-2029
  • 世界の生物学的原薬製造の販売：地域別
    • 世界の生物学的原薬製造の販売：地域別: 2018 VS 2022 VS 2029
    • 世界の生物学的原薬製造の販売：地域別 (2018-2023)
    • 世界の生物学的原薬製造の販売：地域別 (2024-2029)
    • 世界の生物学的原薬製造の販売市場シェア 地域別 (2018-2029)
  • US & カナダ
  • 欧州
  • 中国
  • アジア（中国を除く）
  • 中東, アフリカ ・ラテンアメリカ

第4章 競合：企業別

  • 世界の生物学的原薬製造の販売：企業別
    • 世界の生物学的原薬製造の販売：企業別 (2018-2023)
    • 世界の生物学的原薬製造の販売市場シェア：企業別 (2018-2023)
    • 世界の上位10・上位5企業： 生物学的原薬製造 in 2022
  • 世界の生物学的原薬製造の収益：企業別
    • 世界の生物学的原薬製造の収益：企業別 (2018-2023)
    • 世界の生物学的原薬製造の収益市場シェア：企業別 (2018-2023)
    • 世界の上位10・上位5企業： 生物学的原薬製造の収益 2022
  • 世界の生物学的原薬製造の販売価格：企業別
  • 世界の主要企業 生物学的原薬製造, 業界ランキング, 2021 VS 2022 VS 2023
  • 競合情勢の分析
    • 企業の市場集中度 (CR5 and HHI)
    • 世界の生物学的原薬製造の市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 世界の主要メーカー 生物学的原薬製造, 製造拠点分布と本社
  • 世界の主要メーカー 生物学的原薬製造, 提供製品と用途
  • 世界の主要メーカー 生物学的原薬製造, 業界参入時期
  • M&A, 拡張計画

第5章 市場規模：タイプ別

  • 世界の生物学的原薬製造の販売：タイプ別
    • 世界の生物学的原薬製造の販売実績：タイプ別 (2018-2023)
    • 世界の生物学的原薬製造の販売予測：タイプ別 (2024-2029)
    • 世界の生物学的原薬製造の販売市場シェア：タイプ別 (2018-2029)
  • 世界の生物学的原薬製造 収益：タイプ別
    • 世界の生物学的原薬製造の収益実績：タイプ別 (2018-2023)
    • 世界の生物学的原薬製造の収益予測：タイプ別 (2024-2029)
    • 世界の生物学的原薬製造の収益市場シェア：タイプ別 (2018-2029)
  • 世界の生物学的原薬製造の価格：タイプ別
    • 世界の生物学的原薬製造の価格：タイプ別 (2018-2023)
    • 世界の生物学的原薬製造の価格予測：タイプ別 (2024-2029)

第6章 市場規模：用途別

  • 世界の生物学的原薬製造の販売：用途別
    • 世界の生物学的原薬製造の販売実績：用途別 (2018-2023)
    • 世界の生物学的原薬製造の販売予測：用途別 (2024-2029)
    • 世界の生物学的原薬製造の販売市場シェア：用途別 (2018-2029)
  • 世界の生物学的原薬製造の収益：用途別
    • 世界の生物学的原薬製造の収益実績：用途別 (2018-2023)
    • 世界の生物学的原薬製造の収益予測：用途別 (2024-2029)
    • 世界の生物学的原薬製造の収益市場シェア：用途別 (2018-2029)
  • 世界の生物学的原薬製造の価格：用途別
    • 世界の生物学的原薬製造の価格：用途別 (2018-2023)
    • 世界の生物学的原薬製造の価格予測：用途別 (2024-2029)

第7章 US & カナダ

  • US & カナダ 生物学的原薬製造 市場規模：タイプ別
    • US & カナダ 生物学的原薬製造の販売：タイプ別 (2018-2029)
    • US & カナダ 生物学的原薬製造 収益：タイプ別 (2018-2029)
  • US & カナダ 生物学的原薬製造 市場規模：用途別
    • US & カナダ 生物学的原薬製造の販売：用途別 (2018-2029)
    • US & カナダ 生物学的原薬製造の収益：用途別 (2018-2029)
  • US & カナダ 生物学的原薬製造の販売：国別
    • US & カナダ 生物学的原薬製造の収益：国別: 2018 VS 2022 VS 2029
    • US & カナダ 生物学的原薬製造の販売：国別 (2018-2029)
    • US & カナダ 生物学的原薬製造の収益：国別 (2018-2029)
    • 米国
    • カナダ

第8章 欧州

  • 欧州の生物学的原薬製造 市場規模：タイプ別
    • 欧州の生物学的原薬製造の販売：タイプ別 (2018-2029)
    • 欧州の生物学的原薬製造 収益：タイプ別 (2018-2029)
  • 欧州の生物学的原薬製造 市場規模：用途別
    • 欧州の生物学的原薬製造の販売：用途別 (2018-2029)
    • 欧州の生物学的原薬製造の収益：用途別 (2018-2029)
  • 欧州の生物学的原薬製造の販売：国別
    • 欧州の生物学的原薬製造の収益：国別: 2018 VS 2022 VS 2029
    • 欧州の生物学的原薬製造の販売：国別 (2018-2029)
    • 欧州の生物学的原薬製造の収益：国別 (2018-2029)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア

第9章 中国

  • 中国の生物学的原薬製造 市場規模：タイプ別
    • 中国の生物学的原薬製造の販売：タイプ別 (2018-2029)
    • 中国の生物学的原薬製造 収益：タイプ別 (2018-2029)
  • 中国の生物学的原薬製造 市場規模：用途別
    • 中国の生物学的原薬製造の販売：用途別 (2018-2029)
    • 中国の生物学的原薬製造の収益：用途別 (2018-2029)

第10章 アジア（中国を除く）

  • アジア地域 生物学的原薬製造 市場規模：タイプ別
    • アジア地域 生物学的原薬製造の販売：タイプ別 (2018-2029)
    • アジア地域 生物学的原薬製造 収益：タイプ別 (2018-2029)
  • アジア地域 生物学的原薬製造 市場規模：用途別
    • アジア地域 生物学的原薬製造の販売：用途別 (2018-2029)
    • アジア地域 生物学的原薬製造の収益：用途別 (2018-2029)
  • アジア地域 生物学的原薬製造の販売：地域別
    • アジア地域 生物学的原薬製造の収益：地域別: 2018 VS 2022 VS 2029
    • アジア地域 生物学的原薬製造の収益：地域別 (2018-2029)
    • アジア地域 生物学的原薬製造の販売：地域別 (2018-2029)
    • 日本
    • 韓国
    • 台湾
    • 東南アジア
    • インド

第11章 中東, アフリカ ・ラテンアメリカ

  • 中東, アフリカ ・ラテンアメリカの生物学的原薬製造 市場規模：タイプ別
    • 中東, アフリカ ・ラテンアメリカの生物学的原薬製造の販売：タイプ別 (2018-2029)
    • 中東, アフリカ ・ラテンアメリカの生物学的原薬製造 収益：タイプ別 (2018-2029)
  • 中東, アフリカ ・ラテンアメリカの生物学的原薬製造 市場規模：用途別
    • 中東, アフリカ ・ラテンアメリカの生物学的原薬製造の販売：用途別 (2018-2029)
    • 中東, アフリカ ・ラテンアメリカの生物学的原薬製造の収益：用途別 (2018-2029)
  • 中東, アフリカ ・ラテンアメリカの生物学的原薬製造の販売：国別
    • 中東, アフリカ ・ラテンアメリカの生物学的原薬製造の収益：国別: 2018 VS 2022 VS 2029
    • 中東, アフリカ ・ラテンアメリカの生物学的原薬製造の収益：国別 (2018-2029)
    • 中東, アフリカ ・ラテンアメリカの生物学的原薬製造の販売：国別 (2018-2029)
    • ブラジル
    • メキシコ
    • トルコ
    • イスラエル
    • 湾岸協力理事会諸国

第12章 企業プロファイル

  • Lonza
  • Boehringer Ingelheim BioXcellence
  • Celltrion
  • DSM
  • Samsung BioLogics
  • Fujifilm Diosynth Biotechnologies
  • Cytovance Biologics
  • AbbVie
  • Baxter
  • CEPiA Sanofi
  • GSK
  • Pfizer CentreOne
  • Sandoz
  • Vetter
  • Wuxi Biologics

第13章 業界チェーンと販売チャネルの分析

  • 生物学的原薬製造 業界チェーン分析
  • 生物学的原薬製造 主要原材料
    • 主要原材料
    • 原材料の主要サプライヤー
  • 生物学的原薬製造 生産形態とプロセス
  • 生物学的原薬製造 販売およびマーケティング
    • 生物学的原薬製造 販売チャネル
    • 生物学的原薬製造 卸業者
  • 生物学的原薬製造 顧客

第14章 生物学的原薬製造 市場動向

  • 生物学的原薬製造 業界動向
  • 生物学的原薬製造 市場の促進要因
  • 生物学的原薬製造 市場の課題
  • 生物学的原薬製造 市場の抑制要因

第15章 世界の生物学的原薬製造の主な市場調査結果

第16章 付録

図表

List of Tables

  • Table 1. Global Biological API Drug Manufacturing Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
  • Table 2. Major Manufacturers of In-House manufacturing
  • Table 3. Major Manufacturers of Contract manufacturing
  • Table 4. Global Biological API Drug Manufacturing Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
  • Table 5. Global Biological API Drug Manufacturing Production by Region: 2018 VS 2022 VS 2029 (K MT)
  • Table 6. Global Biological API Drug Manufacturing Production by Region (2018-2023) & (K MT)
  • Table 7. Global Biological API Drug Manufacturing Production by Region (2024-2029) & (K MT)
  • Table 8. Global Biological API Drug Manufacturing Production Market Share by Region (2018-2023)
  • Table 9. Global Biological API Drug Manufacturing Production Market Share by Region (2024-2029)
  • Table 10. Global Biological API Drug Manufacturing Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 11. Global Biological API Drug Manufacturing Revenue by Region (2018-2023) & (US$ Million)
  • Table 12. Global Biological API Drug Manufacturing Revenue by Region (2024-2029) & (US$ Million)
  • Table 13. Global Biological API Drug Manufacturing Revenue Market Share by Region (2018-2023)
  • Table 14. Global Biological API Drug Manufacturing Revenue Market Share by Region (2024-2029)
  • Table 15. Global Biological API Drug Manufacturing Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 16. Global Biological API Drug Manufacturing Sales by Region (2018-2023) & (K MT)
  • Table 17. Global Biological API Drug Manufacturing Sales by Region (2024-2029) & (K MT)
  • Table 18. Global Biological API Drug Manufacturing Sales Market Share by Region (2018-2023)
  • Table 19. Global Biological API Drug Manufacturing Sales Market Share by Region (2024-2029)
  • Table 20. Global Biological API Drug Manufacturing Sales by Manufacturers (2018-2023) & (K MT)
  • Table 21. Global Biological API Drug Manufacturing Sales Share by Manufacturers (2018-2023)
  • Table 22. Global Biological API Drug Manufacturing Revenue by Manufacturers (2018-2023) & (US$ Million)
  • Table 23. Global Biological API Drug Manufacturing Revenue Share by Manufacturers (2018-2023)
  • Table 24. Biological API Drug Manufacturing Price by Manufacturers 2018-2023 (USD/MT)
  • Table 25. Global Key Players of Biological API Drug Manufacturing, Industry Ranking, 2021 VS 2022 VS 2023
  • Table 26. Global Biological API Drug Manufacturing Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 27. Global Biological API Drug Manufacturing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biological API Drug Manufacturing as of 2022)
  • Table 28. Global Key Manufacturers of Biological API Drug Manufacturing, Manufacturing Base Distribution and Headquarters
  • Table 29. Global Key Manufacturers of Biological API Drug Manufacturing, Product Offered and Application
  • Table 30. Global Key Manufacturers of Biological API Drug Manufacturing, Date of Enter into This Industry
  • Table 31. Mergers & Acquisitions, Expansion Plans
  • Table 32. Global Biological API Drug Manufacturing Sales by Type (2018-2023) & (K MT)
  • Table 33. Global Biological API Drug Manufacturing Sales by Type (2024-2029) & (K MT)
  • Table 34. Global Biological API Drug Manufacturing Sales Share by Type (2018-2023)
  • Table 35. Global Biological API Drug Manufacturing Sales Share by Type (2024-2029)
  • Table 36. Global Biological API Drug Manufacturing Revenue by Type (2018-2023) & (US$ Million)
  • Table 37. Global Biological API Drug Manufacturing Revenue by Type (2024-2029) & (US$ Million)
  • Table 38. Global Biological API Drug Manufacturing Revenue Share by Type (2018-2023)
  • Table 39. Global Biological API Drug Manufacturing Revenue Share by Type (2024-2029)
  • Table 40. Biological API Drug Manufacturing Price by Type (2018-2023) & (USD/MT)
  • Table 41. Global Biological API Drug Manufacturing Price Forecast by Type (2024-2029) & (USD/MT)
  • Table 42. Global Biological API Drug Manufacturing Sales by Application (2018-2023) & (K MT)
  • Table 43. Global Biological API Drug Manufacturing Sales by Application (2024-2029) & (K MT)
  • Table 44. Global Biological API Drug Manufacturing Sales Share by Application (2018-2023)
  • Table 45. Global Biological API Drug Manufacturing Sales Share by Application (2024-2029)
  • Table 46. Global Biological API Drug Manufacturing Revenue by Application (2018-2023) & (US$ Million)
  • Table 47. Global Biological API Drug Manufacturing Revenue by Application (2024-2029) & (US$ Million)
  • Table 48. Global Biological API Drug Manufacturing Revenue Share by Application (2018-2023)
  • Table 49. Global Biological API Drug Manufacturing Revenue Share by Application (2024-2029)
  • Table 50. Biological API Drug Manufacturing Price by Application (2018-2023) & (USD/MT)
  • Table 51. Global Biological API Drug Manufacturing Price Forecast by Application (2024-2029) & (USD/MT)
  • Table 52. US & Canada Biological API Drug Manufacturing Sales by Type (2018-2023) & (K MT)
  • Table 53. US & Canada Biological API Drug Manufacturing Sales by Type (2024-2029) & (K MT)
  • Table 54. US & Canada Biological API Drug Manufacturing Revenue by Type (2018-2023) & (US$ Million)
  • Table 55. US & Canada Biological API Drug Manufacturing Revenue by Type (2024-2029) & (US$ Million)
  • Table 56. US & Canada Biological API Drug Manufacturing Sales by Application (2018-2023) & (K MT)
  • Table 57. US & Canada Biological API Drug Manufacturing Sales by Application (2024-2029) & (K MT)
  • Table 58. US & Canada Biological API Drug Manufacturing Revenue by Application (2018-2023) & (US$ Million)
  • Table 59. US & Canada Biological API Drug Manufacturing Revenue by Application (2024-2029) & (US$ Million)
  • Table 60. US & Canada Biological API Drug Manufacturing Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 61. US & Canada Biological API Drug Manufacturing Revenue by Country (2018-2023) & (US$ Million)
  • Table 62. US & Canada Biological API Drug Manufacturing Revenue by Country (2024-2029) & (US$ Million)
  • Table 63. US & Canada Biological API Drug Manufacturing Sales by Country (2018-2023) & (K MT)
  • Table 64. US & Canada Biological API Drug Manufacturing Sales by Country (2024-2029) & (K MT)
  • Table 65. Europe Biological API Drug Manufacturing Sales by Type (2018-2023) & (K MT)
  • Table 66. Europe Biological API Drug Manufacturing Sales by Type (2024-2029) & (K MT)
  • Table 67. Europe Biological API Drug Manufacturing Revenue by Type (2018-2023) & (US$ Million)
  • Table 68. Europe Biological API Drug Manufacturing Revenue by Type (2024-2029) & (US$ Million)
  • Table 69. Europe Biological API Drug Manufacturing Sales by Application (2018-2023) & (K MT)
  • Table 70. Europe Biological API Drug Manufacturing Sales by Application (2024-2029) & (K MT)
  • Table 71. Europe Biological API Drug Manufacturing Revenue by Application (2018-2023) & (US$ Million)
  • Table 72. Europe Biological API Drug Manufacturing Revenue by Application (2024-2029) & (US$ Million)
  • Table 73. Europe Biological API Drug Manufacturing Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 74. Europe Biological API Drug Manufacturing Revenue by Country (2018-2023) & (US$ Million)
  • Table 75. Europe Biological API Drug Manufacturing Revenue by Country (2024-2029) & (US$ Million)
  • Table 76. Europe Biological API Drug Manufacturing Sales by Country (2018-2023) & (K MT)
  • Table 77. Europe Biological API Drug Manufacturing Sales by Country (2024-2029) & (K MT)
  • Table 78. China Biological API Drug Manufacturing Sales by Type (2018-2023) & (K MT)
  • Table 79. China Biological API Drug Manufacturing Sales by Type (2024-2029) & (K MT)
  • Table 80. China Biological API Drug Manufacturing Revenue by Type (2018-2023) & (US$ Million)
  • Table 81. China Biological API Drug Manufacturing Revenue by Type (2024-2029) & (US$ Million)
  • Table 82. China Biological API Drug Manufacturing Sales by Application (2018-2023) & (K MT)
  • Table 83. China Biological API Drug Manufacturing Sales by Application (2024-2029) & (K MT)
  • Table 84. China Biological API Drug Manufacturing Revenue by Application (2018-2023) & (US$ Million)
  • Table 85. China Biological API Drug Manufacturing Revenue by Application (2024-2029) & (US$ Million)
  • Table 86. Asia Biological API Drug Manufacturing Sales by Type (2018-2023) & (K MT)
  • Table 87. Asia Biological API Drug Manufacturing Sales by Type (2024-2029) & (K MT)
  • Table 88. Asia Biological API Drug Manufacturing Revenue by Type (2018-2023) & (US$ Million)
  • Table 89. Asia Biological API Drug Manufacturing Revenue by Type (2024-2029) & (US$ Million)
  • Table 90. Asia Biological API Drug Manufacturing Sales by Application (2018-2023) & (K MT)
  • Table 91. Asia Biological API Drug Manufacturing Sales by Application (2024-2029) & (K MT)
  • Table 92. Asia Biological API Drug Manufacturing Revenue by Application (2018-2023) & (US$ Million)
  • Table 93. Asia Biological API Drug Manufacturing Revenue by Application (2024-2029) & (US$ Million)
  • Table 94. Asia Biological API Drug Manufacturing Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 95. Asia Biological API Drug Manufacturing Revenue by Region (2018-2023) & (US$ Million)
  • Table 96. Asia Biological API Drug Manufacturing Revenue by Region (2024-2029) & (US$ Million)
  • Table 97. Asia Biological API Drug Manufacturing Sales by Region (2018-2023) & (K MT)
  • Table 98. Asia Biological API Drug Manufacturing Sales by Region (2024-2029) & (K MT)
  • Table 99. Middle East, Africa and Latin America Biological API Drug Manufacturing Sales by Type (2018-2023) & (K MT)
  • Table 100. Middle East, Africa and Latin America Biological API Drug Manufacturing Sales by Type (2024-2029) & (K MT)
  • Table 101. Middle East, Africa and Latin America Biological API Drug Manufacturing Revenue by Type (2018-2023) & (US$ Million)
  • Table 102. Middle East, Africa and Latin America Biological API Drug Manufacturing Revenue by Type (2024-2029) & (US$ Million)
  • Table 103. Middle East, Africa and Latin America Biological API Drug Manufacturing Sales by Application (2018-2023) & (K MT)
  • Table 104. Middle East, Africa and Latin America Biological API Drug Manufacturing Sales by Application (2024-2029) & (K MT)
  • Table 105. Middle East, Africa and Latin America Biological API Drug Manufacturing Revenue by Application (2018-2023) & (US$ Million)
  • Table 106. Middle East, Africa and Latin America Biological API Drug Manufacturing Revenue by Application (2024-2029) & (US$ Million)
  • Table 107. Middle East, Africa and Latin America Biological API Drug Manufacturing Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 108. Middle East, Africa and Latin America Biological API Drug Manufacturing Revenue by Country (2018-2023) & (US$ Million)
  • Table 109. Middle East, Africa and Latin America Biological API Drug Manufacturing Revenue by Country (2024-2029) & (US$ Million)
  • Table 110. Middle East, Africa and Latin America Biological API Drug Manufacturing Sales by Country (2018-2023) & (K MT)
  • Table 111. Middle East, Africa and Latin America Biological API Drug Manufacturing Sales by Country (2024-2029) & (K MT)
  • Table 112. Lonza Company Information
  • Table 113. Lonza Description and Major Businesses
  • Table 114. Lonza Biological API Drug Manufacturing Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
  • Table 115. Lonza Biological API Drug Manufacturing Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 116. Lonza Recent Development
  • Table 117. Boehringer Ingelheim BioXcellence Company Information
  • Table 118. Boehringer Ingelheim BioXcellence Description and Major Businesses
  • Table 119. Boehringer Ingelheim BioXcellence Biological API Drug Manufacturing Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
  • Table 120. Boehringer Ingelheim BioXcellence Biological API Drug Manufacturing Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 121. Boehringer Ingelheim BioXcellence Recent Development
  • Table 122. Celltrion Company Information
  • Table 123. Celltrion Description and Major Businesses
  • Table 124. Celltrion Biological API Drug Manufacturing Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
  • Table 125. Celltrion Biological API Drug Manufacturing Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 126. Celltrion Recent Development
  • Table 127. DSM Company Information
  • Table 128. DSM Description and Major Businesses
  • Table 129. DSM Biological API Drug Manufacturing Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
  • Table 130. DSM Biological API Drug Manufacturing Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 131. DSM Recent Development
  • Table 132. Samsung BioLogics Company Information
  • Table 133. Samsung BioLogics Description and Major Businesses
  • Table 134. Samsung BioLogics Biological API Drug Manufacturing Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
  • Table 135. Samsung BioLogics Biological API Drug Manufacturing Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 136. Samsung BioLogics Recent Development
  • Table 137. Fujifilm Diosynth Biotechnologies Company Information
  • Table 138. Fujifilm Diosynth Biotechnologies Description and Major Businesses
  • Table 139. Fujifilm Diosynth Biotechnologies Biological API Drug Manufacturing Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
  • Table 140. Fujifilm Diosynth Biotechnologies Biological API Drug Manufacturing Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 141. Fujifilm Diosynth Biotechnologies Recent Development
  • Table 142. Cytovance Biologics Company Information
  • Table 143. Cytovance Biologics Description and Major Businesses
  • Table 144. Cytovance Biologics Biological API Drug Manufacturing Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
  • Table 145. Cytovance Biologics Biological API Drug Manufacturing Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 146. Cytovance Biologics Recent Development
  • Table 147. AbbVie Company Information
  • Table 148. AbbVie Description and Major Businesses
  • Table 149. AbbVie Biological API Drug Manufacturing Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
  • Table 150. AbbVie Biological API Drug Manufacturing Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 151. AbbVie Recent Development
  • Table 152. Baxter Company Information
  • Table 153. Baxter Description and Major Businesses
  • Table 154. Baxter Biological API Drug Manufacturing Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
  • Table 155. Baxter Biological API Drug Manufacturing Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 156. Baxter Recent Development
  • Table 157. CEPiA Sanofi Company Information
  • Table 158. CEPiA Sanofi Description and Major Businesses
  • Table 159. CEPiA Sanofi Biological API Drug Manufacturing Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
  • Table 160. CEPiA Sanofi Biological API Drug Manufacturing Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 161. CEPiA Sanofi Recent Development
  • Table 162. GSK Company Information
  • Table 163. GSK Description and Major Businesses
  • Table 164. GSK Biological API Drug Manufacturing Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
  • Table 165. GSK Biological API Drug Manufacturing Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 166. GSK Recent Development
  • Table 167. Pfizer CentreOne Company Information
  • Table 168. Pfizer CentreOne Description and Major Businesses
  • Table 169. Pfizer CentreOne Biological API Drug Manufacturing Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
  • Table 170. Pfizer CentreOne Biological API Drug Manufacturing Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 171. Pfizer CentreOne Recent Development
  • Table 172. Sandoz Company Information
  • Table 173. Sandoz Description and Major Businesses
  • Table 174. Sandoz Biological API Drug Manufacturing Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
  • Table 175. Sandoz Biological API Drug Manufacturing Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 176. Sandoz Recent Development
  • Table 177. Vetter Company Information
  • Table 178. Vetter Description and Major Businesses
  • Table 179. Vetter Biological API Drug Manufacturing Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
  • Table 180. Vetter Biological API Drug Manufacturing Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 181. Vetter Recent Development
  • Table 182. Wuxi Biologics Company Information
  • Table 183. Wuxi Biologics Description and Major Businesses
  • Table 184. Wuxi Biologics Biological API Drug Manufacturing Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
  • Table 185. Wuxi Biologics Biological API Drug Manufacturing Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 186. Wuxi Biologics Recent Development
  • Table 187. Key Raw Materials Lists
  • Table 188. Raw Materials Key Suppliers Lists
  • Table 189. Biological API Drug Manufacturing Distributors List
  • Table 190. Biological API Drug Manufacturing Customers List
  • Table 191. Biological API Drug Manufacturing Market Trends
  • Table 192. Biological API Drug Manufacturing Market Drivers
  • Table 193. Biological API Drug Manufacturing Market Challenges
  • Table 194. Biological API Drug Manufacturing Market Restraints
  • Table 195. Research Programs/Design for This Report
  • Table 196. Key Data Information from Secondary Sources
  • Table 197. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Biological API Drug Manufacturing Product Picture
  • Figure 2. Global Biological API Drug Manufacturing Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 3. Global Biological API Drug Manufacturing Market Share by Type in 2022 & 2029
  • Figure 4. In-House manufacturing Product Picture
  • Figure 5. Contract manufacturing Product Picture
  • Figure 6. Global Biological API Drug Manufacturing Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 7. Global Biological API Drug Manufacturing Market Share by Application in 2022 & 2029
  • Figure 8. Monoclonal Antibody (mAb) Therapies
  • Figure 9. Vaccines
  • Figure 10. Insulin Therapies
  • Figure 11. Interferon Therapies
  • Figure 12. Other
  • Figure 13. Biological API Drug Manufacturing Report Years Considered
  • Figure 14. Global Biological API Drug Manufacturing Capacity, Production and Utilization (2018-2029) & (K MT)
  • Figure 15. Global Biological API Drug Manufacturing Production Market Share by Region in Percentage: 2022 Versus 2029
  • Figure 16. Global Biological API Drug Manufacturing Production Market Share by Region (2018-2029)
  • Figure 17. Biological API Drug Manufacturing Production Growth Rate in North America (2018-2029) & (K MT)
  • Figure 18. Biological API Drug Manufacturing Production Growth Rate in Europe (2018-2029) & (K MT)
  • Figure 19. Biological API Drug Manufacturing Production Growth Rate in China (2018-2029) & (K MT)
  • Figure 20. Biological API Drug Manufacturing Production Growth Rate in Japan (2018-2029) & (K MT)
  • Figure 21. Global Biological API Drug Manufacturing Revenue, (US$ Million), 2018 VS 2022 VS 2029
  • Figure 22. Global Biological API Drug Manufacturing Revenue 2018-2029 (US$ Million)
  • Figure 23. Global Biological API Drug Manufacturing Revenue (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 24. Global Biological API Drug Manufacturing Revenue Market Share by Region in Percentage: 2022 Versus 2029
  • Figure 25. Global Biological API Drug Manufacturing Revenue Market Share by Region (2018-2029)
  • Figure 26. Global Biological API Drug Manufacturing Sales 2018-2029 ((K MT)
  • Figure 27. Global Biological API Drug Manufacturing Sales (CAGR) by Region: 2018 VS 2022 VS 2029 (K MT)
  • Figure 28. Global Biological API Drug Manufacturing Sales Market Share by Region (2018-2029)
  • Figure 29. US & Canada Biological API Drug Manufacturing Sales YoY (2018-2029) & (K MT)
  • Figure 30. US & Canada Biological API Drug Manufacturing Revenue YoY (2018-2029) & (US$ Million)
  • Figure 31. Europe Biological API Drug Manufacturing Sales YoY (2018-2029) & (K MT)
  • Figure 32. Europe Biological API Drug Manufacturing Revenue YoY (2018-2029) & (US$ Million)
  • Figure 33. China Biological API Drug Manufacturing Sales YoY (2018-2029) & (K MT)
  • Figure 34. China Biological API Drug Manufacturing Revenue YoY (2018-2029) & (US$ Million)
  • Figure 35. Asia (excluding China) Biological API Drug Manufacturing Sales YoY (2018-2029) & (K MT)
  • Figure 36. Asia (excluding China) Biological API Drug Manufacturing Revenue YoY (2018-2029) & (US$ Million)
  • Figure 37. Middle East, Africa and Latin America Biological API Drug Manufacturing Sales YoY (2018-2029) & (K MT)
  • Figure 38. Middle East, Africa and Latin America Biological API Drug Manufacturing Revenue YoY (2018-2029) & (US$ Million)
  • Figure 39. The Biological API Drug Manufacturing Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
  • Figure 40. The Top 5 and 10 Largest Manufacturers of Biological API Drug Manufacturing in the World: Market Share by Biological API Drug Manufacturing Revenue in 2022
  • Figure 41. Global Biological API Drug Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
  • Figure 42. Global Biological API Drug Manufacturing Sales Market Share by Type (2018-2029)
  • Figure 43. Global Biological API Drug Manufacturing Revenue Market Share by Type (2018-2029)
  • Figure 44. Global Biological API Drug Manufacturing Sales Market Share by Application (2018-2029)
  • Figure 45. Global Biological API Drug Manufacturing Revenue Market Share by Application (2018-2029)
  • Figure 46. US & Canada Biological API Drug Manufacturing Sales Market Share by Type (2018-2029)
  • Figure 47. US & Canada Biological API Drug Manufacturing Revenue Market Share by Type (2018-2029)
  • Figure 48. US & Canada Biological API Drug Manufacturing Sales Market Share by Application (2018-2029)
  • Figure 49. US & Canada Biological API Drug Manufacturing Revenue Market Share by Application (2018-2029)
  • Figure 50. US & Canada Biological API Drug Manufacturing Revenue Share by Country (2018-2029)
  • Figure 51. US & Canada Biological API Drug Manufacturing Sales Share by Country (2018-2029)
  • Figure 52. U.S. Biological API Drug Manufacturing Revenue (2018-2029) & (US$ Million)
  • Figure 53. Canada Biological API Drug Manufacturing Revenue (2018-2029) & (US$ Million)
  • Figure 54. Europe Biological API Drug Manufacturing Sales Market Share by Type (2018-2029)
  • Figure 55. Europe Biological API Drug Manufacturing Revenue Market Share by Type (2018-2029)
  • Figure 56. Europe Biological API Drug Manufacturing Sales Market Share by Application (2018-2029)
  • Figure 57. Europe Biological API Drug Manufacturing Revenue Market Share by Application (2018-2029)
  • Figure 58. Europe Biological API Drug Manufacturing Revenue Share by Country (2018-2029)
  • Figure 59. Europe Biological API Drug Manufacturing Sales Share by Country (2018-2029)
  • Figure 60. Germany Biological API Drug Manufacturing Revenue (2018-2029) & (US$ Million)
  • Figure 61. France Biological API Drug Manufacturing Revenue (2018-2029) & (US$ Million)
  • Figure 62. U.K. Biological API Drug Manufacturing Revenue (2018-2029) & (US$ Million)
  • Figure 63. Italy Biological API Drug Manufacturing Revenue (2018-2029) & (US$ Million)
  • Figure 64. Russia Biological API Drug Manufacturing Revenue (2018-2029) & (US$ Million)
  • Figure 65. China Biological API Drug Manufacturing Sales Market Share by Type (2018-2029)
  • Figure 66. China Biological API Drug Manufacturing Revenue Market Share by Type (2018-2029)
  • Figure 67. China Biological API Drug Manufacturing Sales Market Share by Application (2018-2029)
  • Figure 68. China Biological API Drug Manufacturing Revenue Market Share by Application (2018-2029)
  • Figure 69. Asia Biological API Drug Manufacturing Sales Market Share by Type (2018-2029)
  • Figure 70. Asia Biological API Drug Manufacturing Revenue Market Share by Type (2018-2029)
  • Figure 71. Asia Biological API Drug Manufacturing Sales Market Share by Application (2018-2029)
  • Figure 72. Asia Biological API Drug Manufacturing Revenue Market Share by Application (2018-2029)
  • Figure 73. Asia Biological API Drug Manufacturing Revenue Share by Region (2018-2029)
  • Figure 74. Asia Biological API Drug Manufacturing Sales Share by Region (2018-2029)
  • Figure 75. Japan Biological API Drug Manufacturing Revenue (2018-2029) & (US$ Million)
  • Figure 76. South Korea Biological API Drug Manufacturing Revenue (2018-2029) & (US$ Million)
  • Figure 77. China Taiwan Biological API Drug Manufacturing Revenue (2018-2029) & (US$ Million)
  • Figure 78. Southeast Asia Biological API Drug Manufacturing Revenue (2018-2029) & (US$ Million)
  • Figure 79. India Biological API Drug Manufacturing Revenue (2018-2029) & (US$ Million)
  • Figure 80. Middle East, Africa and Latin America Biological API Drug Manufacturing Sales Market Share by Type (2018-2029)
  • Figure 81. Middle East, Africa and Latin America Biological API Drug Manufacturing Revenue Market Share by Type (2018-2029)
  • Figure 82. Middle East, Africa and Latin America Biological API Drug Manufacturing Sales Market Share by Application (2018-2029)
  • Figure 83. Middle East, Africa and Latin America Biological API Drug Manufacturing Revenue Market Share by Application (2018-2029)
  • Figure 84. Middle East, Africa and Latin America Biological API Drug Manufacturing Revenue Share by Country (2018-2029)
  • Figure 85. Middle East, Africa and Latin America Biological API Drug Manufacturing Sales Share by Country (2018-2029)
  • Figure 86. Brazil Biological API Drug Manufacturing Revenue (2018-2029) & (US$ Million)
  • Figure 87. Mexico Biological API Drug Manufacturing Revenue (2018-2029) & (US$ Million)
  • Figure 88. Turkey Biological API Drug Manufacturing Revenue (2018-2029) & (US$ Million)
  • Figure 89. Israel Biological API Drug Manufacturing Revenue (2018-2029) & (US$ Million)
  • Figure 90. GCC Countries Biological API Drug Manufacturing Revenue (2018-2029) & (US$ Million)
  • Figure 91. Biological API Drug Manufacturing Value Chain
  • Figure 92. Biological API Drug Manufacturing Production Process
  • Figure 93. Channels of Distribution
  • Figure 94. Distributors Profiles
  • Figure 95. Bottom-up and Top-down Approaches for This Report
  • Figure 96. Data Triangulation
  • Figure 97. Key Executives Interviewed
目次

This research report focuses on the Biological API Drug Manufacturing Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Study Coverage

  • 1.1 Biological API Drug Manufacturing Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Biological API Drug Manufacturing Market Size by Type, 2018 VS 2022 VS 2029
    • 1.2.2 In-House manufacturing
    • 1.2.3 Contract manufacturing
  • 1.3 Market by Application
    • 1.3.1 Global Biological API Drug Manufacturing Market Size by Application, 2018 VS 2022 VS 2029
    • 1.3.2 Monoclonal Antibody (mAb) Therapies
    • 1.3.3 Vaccines
    • 1.3.4 Insulin Therapies
    • 1.3.5 Interferon Therapies
    • 1.3.6 Other
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Biological API Drug Manufacturing Production

  • 2.1 Global Biological API Drug Manufacturing Production Capacity (2018-2029)
  • 2.2 Global Biological API Drug Manufacturing Production by Region: 2018 VS 2022 VS 2029
  • 2.3 Global Biological API Drug Manufacturing Production by Region
    • 2.3.1 Global Biological API Drug Manufacturing Historic Production by Region (2018-2023)
    • 2.3.2 Global Biological API Drug Manufacturing Forecasted Production by Region (2024-2029)
    • 2.3.3 Global Biological API Drug Manufacturing Production Market Share by Region (2018-2029)
  • 2.4 North America
  • 2.5 Europe
  • 2.6 China
  • 2.7 Japan

3 Executive Summary

  • 3.1 Global Biological API Drug Manufacturing Revenue Estimates and Forecasts 2018-2029
  • 3.2 Global Biological API Drug Manufacturing Revenue by Region
    • 3.2.1 Global Biological API Drug Manufacturing Revenue by Region: 2018 VS 2022 VS 2029
    • 3.2.2 Global Biological API Drug Manufacturing Revenue by Region (2018-2023)
    • 3.2.3 Global Biological API Drug Manufacturing Revenue by Region (2024-2029)
    • 3.2.4 Global Biological API Drug Manufacturing Revenue Market Share by Region (2018-2029)
  • 3.3 Global Biological API Drug Manufacturing Sales Estimates and Forecasts 2018-2029
  • 3.4 Global Biological API Drug Manufacturing Sales by Region
    • 3.4.1 Global Biological API Drug Manufacturing Sales by Region: 2018 VS 2022 VS 2029
    • 3.4.2 Global Biological API Drug Manufacturing Sales by Region (2018-2023)
    • 3.4.3 Global Biological API Drug Manufacturing Sales by Region (2024-2029)
    • 3.4.4 Global Biological API Drug Manufacturing Sales Market Share by Region (2018-2029)
  • 3.5 US & Canada
  • 3.6 Europe
  • 3.7 China
  • 3.8 Asia (excluding China)
  • 3.9 Middle East, Africa and Latin America

4 Competition by Manufactures

  • 4.1 Global Biological API Drug Manufacturing Sales by Manufacturers
    • 4.1.1 Global Biological API Drug Manufacturing Sales by Manufacturers (2018-2023)
    • 4.1.2 Global Biological API Drug Manufacturing Sales Market Share by Manufacturers (2018-2023)
    • 4.1.3 Global Top 10 and Top 5 Largest Manufacturers of Biological API Drug Manufacturing in 2022
  • 4.2 Global Biological API Drug Manufacturing Revenue by Manufacturers
    • 4.2.1 Global Biological API Drug Manufacturing Revenue by Manufacturers (2018-2023)
    • 4.2.2 Global Biological API Drug Manufacturing Revenue Market Share by Manufacturers (2018-2023)
    • 4.2.3 Global Top 10 and Top 5 Companies by Biological API Drug Manufacturing Revenue in 2022
  • 4.3 Global Biological API Drug Manufacturing Sales Price by Manufacturers
  • 4.4 Global Key Players of Biological API Drug Manufacturing, Industry Ranking, 2021 VS 2022 VS 2023
  • 4.5 Analysis of Competitive Landscape
    • 4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 4.5.2 Global Biological API Drug Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 4.6 Global Key Manufacturers of Biological API Drug Manufacturing, Manufacturing Base Distribution and Headquarters
  • 4.7 Global Key Manufacturers of Biological API Drug Manufacturing, Product Offered and Application
  • 4.8 Global Key Manufacturers of Biological API Drug Manufacturing, Date of Enter into This Industry
  • 4.9 Mergers & Acquisitions, Expansion Plans

5 Market Size by Type

  • 5.1 Global Biological API Drug Manufacturing Sales by Type
    • 5.1.1 Global Biological API Drug Manufacturing Historical Sales by Type (2018-2023)
    • 5.1.2 Global Biological API Drug Manufacturing Forecasted Sales by Type (2024-2029)
    • 5.1.3 Global Biological API Drug Manufacturing Sales Market Share by Type (2018-2029)
  • 5.2 Global Biological API Drug Manufacturing Revenue by Type
    • 5.2.1 Global Biological API Drug Manufacturing Historical Revenue by Type (2018-2023)
    • 5.2.2 Global Biological API Drug Manufacturing Forecasted Revenue by Type (2024-2029)
    • 5.2.3 Global Biological API Drug Manufacturing Revenue Market Share by Type (2018-2029)
  • 5.3 Global Biological API Drug Manufacturing Price by Type
    • 5.3.1 Global Biological API Drug Manufacturing Price by Type (2018-2023)
    • 5.3.2 Global Biological API Drug Manufacturing Price Forecast by Type (2024-2029)

6 Market Size by Application

  • 6.1 Global Biological API Drug Manufacturing Sales by Application
    • 6.1.1 Global Biological API Drug Manufacturing Historical Sales by Application (2018-2023)
    • 6.1.2 Global Biological API Drug Manufacturing Forecasted Sales by Application (2024-2029)
    • 6.1.3 Global Biological API Drug Manufacturing Sales Market Share by Application (2018-2029)
  • 6.2 Global Biological API Drug Manufacturing Revenue by Application
    • 6.2.1 Global Biological API Drug Manufacturing Historical Revenue by Application (2018-2023)
    • 6.2.2 Global Biological API Drug Manufacturing Forecasted Revenue by Application (2024-2029)
    • 6.2.3 Global Biological API Drug Manufacturing Revenue Market Share by Application (2018-2029)
  • 6.3 Global Biological API Drug Manufacturing Price by Application
    • 6.3.1 Global Biological API Drug Manufacturing Price by Application (2018-2023)
    • 6.3.2 Global Biological API Drug Manufacturing Price Forecast by Application (2024-2029)

7 US & Canada

  • 7.1 US & Canada Biological API Drug Manufacturing Market Size by Type
    • 7.1.1 US & Canada Biological API Drug Manufacturing Sales by Type (2018-2029)
    • 7.1.2 US & Canada Biological API Drug Manufacturing Revenue by Type (2018-2029)
  • 7.2 US & Canada Biological API Drug Manufacturing Market Size by Application
    • 7.2.1 US & Canada Biological API Drug Manufacturing Sales by Application (2018-2029)
    • 7.2.2 US & Canada Biological API Drug Manufacturing Revenue by Application (2018-2029)
  • 7.3 US & Canada Biological API Drug Manufacturing Sales by Country
    • 7.3.1 US & Canada Biological API Drug Manufacturing Revenue by Country: 2018 VS 2022 VS 2029
    • 7.3.2 US & Canada Biological API Drug Manufacturing Sales by Country (2018-2029)
    • 7.3.3 US & Canada Biological API Drug Manufacturing Revenue by Country (2018-2029)
    • 7.3.4 U.S.
    • 7.3.5 Canada

8 Europe

  • 8.1 Europe Biological API Drug Manufacturing Market Size by Type
    • 8.1.1 Europe Biological API Drug Manufacturing Sales by Type (2018-2029)
    • 8.1.2 Europe Biological API Drug Manufacturing Revenue by Type (2018-2029)
  • 8.2 Europe Biological API Drug Manufacturing Market Size by Application
    • 8.2.1 Europe Biological API Drug Manufacturing Sales by Application (2018-2029)
    • 8.2.2 Europe Biological API Drug Manufacturing Revenue by Application (2018-2029)
  • 8.3 Europe Biological API Drug Manufacturing Sales by Country
    • 8.3.1 Europe Biological API Drug Manufacturing Revenue by Country: 2018 VS 2022 VS 2029
    • 8.3.2 Europe Biological API Drug Manufacturing Sales by Country (2018-2029)
    • 8.3.3 Europe Biological API Drug Manufacturing Revenue by Country (2018-2029)
    • 8.3.4 Germany
    • 8.3.5 France
    • 8.3.6 U.K.
    • 8.3.7 Italy
    • 8.3.8 Russia

9 China

  • 9.1 China Biological API Drug Manufacturing Market Size by Type
    • 9.1.1 China Biological API Drug Manufacturing Sales by Type (2018-2029)
    • 9.1.2 China Biological API Drug Manufacturing Revenue by Type (2018-2029)
  • 9.2 China Biological API Drug Manufacturing Market Size by Application
    • 9.2.1 China Biological API Drug Manufacturing Sales by Application (2018-2029)
    • 9.2.2 China Biological API Drug Manufacturing Revenue by Application (2018-2029)

10 Asia (excluding China)

  • 10.1 Asia Biological API Drug Manufacturing Market Size by Type
    • 10.1.1 Asia Biological API Drug Manufacturing Sales by Type (2018-2029)
    • 10.1.2 Asia Biological API Drug Manufacturing Revenue by Type (2018-2029)
  • 10.2 Asia Biological API Drug Manufacturing Market Size by Application
    • 10.2.1 Asia Biological API Drug Manufacturing Sales by Application (2018-2029)
    • 10.2.2 Asia Biological API Drug Manufacturing Revenue by Application (2018-2029)
  • 10.3 Asia Biological API Drug Manufacturing Sales by Region
    • 10.3.1 Asia Biological API Drug Manufacturing Revenue by Region: 2018 VS 2022 VS 2029
    • 10.3.2 Asia Biological API Drug Manufacturing Revenue by Region (2018-2029)
    • 10.3.3 Asia Biological API Drug Manufacturing Sales by Region (2018-2029)
    • 10.3.4 Japan
    • 10.3.5 South Korea
    • 10.3.6 China Taiwan
    • 10.3.7 Southeast Asia
    • 10.3.8 India

11 Middle East, Africa and Latin America

  • 11.1 Middle East, Africa and Latin America Biological API Drug Manufacturing Market Size by Type
    • 11.1.1 Middle East, Africa and Latin America Biological API Drug Manufacturing Sales by Type (2018-2029)
    • 11.1.2 Middle East, Africa and Latin America Biological API Drug Manufacturing Revenue by Type (2018-2029)
  • 11.2 Middle East, Africa and Latin America Biological API Drug Manufacturing Market Size by Application
    • 11.2.1 Middle East, Africa and Latin America Biological API Drug Manufacturing Sales by Application (2018-2029)
    • 11.2.2 Middle East, Africa and Latin America Biological API Drug Manufacturing Revenue by Application (2018-2029)
  • 11.3 Middle East, Africa and Latin America Biological API Drug Manufacturing Sales by Country
    • 11.3.1 Middle East, Africa and Latin America Biological API Drug Manufacturing Revenue by Country: 2018 VS 2022 VS 2029
    • 11.3.2 Middle East, Africa and Latin America Biological API Drug Manufacturing Revenue by Country (2018-2029)
    • 11.3.3 Middle East, Africa and Latin America Biological API Drug Manufacturing Sales by Country (2018-2029)
    • 11.3.4 Brazil
    • 11.3.5 Mexico
    • 11.3.6 Turkey
    • 11.3.7 Israel
    • 11.3.8 GCC Countries

12 Corporate Profiles

  • 12.1 Lonza
    • 12.1.1 Lonza Company Information
    • 12.1.2 Lonza Overview
    • 12.1.3 Lonza Biological API Drug Manufacturing Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
    • 12.1.4 Lonza Biological API Drug Manufacturing Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.1.5 Lonza Recent Developments
  • 12.2 Boehringer Ingelheim BioXcellence
    • 12.2.1 Boehringer Ingelheim BioXcellence Company Information
    • 12.2.2 Boehringer Ingelheim BioXcellence Overview
    • 12.2.3 Boehringer Ingelheim BioXcellence Biological API Drug Manufacturing Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
    • 12.2.4 Boehringer Ingelheim BioXcellence Biological API Drug Manufacturing Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.2.5 Boehringer Ingelheim BioXcellence Recent Developments
  • 12.3 Celltrion
    • 12.3.1 Celltrion Company Information
    • 12.3.2 Celltrion Overview
    • 12.3.3 Celltrion Biological API Drug Manufacturing Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
    • 12.3.4 Celltrion Biological API Drug Manufacturing Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.3.5 Celltrion Recent Developments
  • 12.4 DSM
    • 12.4.1 DSM Company Information
    • 12.4.2 DSM Overview
    • 12.4.3 DSM Biological API Drug Manufacturing Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
    • 12.4.4 DSM Biological API Drug Manufacturing Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.4.5 DSM Recent Developments
  • 12.5 Samsung BioLogics
    • 12.5.1 Samsung BioLogics Company Information
    • 12.5.2 Samsung BioLogics Overview
    • 12.5.3 Samsung BioLogics Biological API Drug Manufacturing Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
    • 12.5.4 Samsung BioLogics Biological API Drug Manufacturing Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.5.5 Samsung BioLogics Recent Developments
  • 12.6 Fujifilm Diosynth Biotechnologies
    • 12.6.1 Fujifilm Diosynth Biotechnologies Company Information
    • 12.6.2 Fujifilm Diosynth Biotechnologies Overview
    • 12.6.3 Fujifilm Diosynth Biotechnologies Biological API Drug Manufacturing Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
    • 12.6.4 Fujifilm Diosynth Biotechnologies Biological API Drug Manufacturing Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.6.5 Fujifilm Diosynth Biotechnologies Recent Developments
  • 12.7 Cytovance Biologics
    • 12.7.1 Cytovance Biologics Company Information
    • 12.7.2 Cytovance Biologics Overview
    • 12.7.3 Cytovance Biologics Biological API Drug Manufacturing Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
    • 12.7.4 Cytovance Biologics Biological API Drug Manufacturing Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.7.5 Cytovance Biologics Recent Developments
  • 12.8 AbbVie
    • 12.8.1 AbbVie Company Information
    • 12.8.2 AbbVie Overview
    • 12.8.3 AbbVie Biological API Drug Manufacturing Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
    • 12.8.4 AbbVie Biological API Drug Manufacturing Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.8.5 AbbVie Recent Developments
  • 12.9 Baxter
    • 12.9.1 Baxter Company Information
    • 12.9.2 Baxter Overview
    • 12.9.3 Baxter Biological API Drug Manufacturing Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
    • 12.9.4 Baxter Biological API Drug Manufacturing Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.9.5 Baxter Recent Developments
  • 12.10 CEPiA Sanofi
    • 12.10.1 CEPiA Sanofi Company Information
    • 12.10.2 CEPiA Sanofi Overview
    • 12.10.3 CEPiA Sanofi Biological API Drug Manufacturing Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
    • 12.10.4 CEPiA Sanofi Biological API Drug Manufacturing Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.10.5 CEPiA Sanofi Recent Developments
  • 12.11 GSK
    • 12.11.1 GSK Company Information
    • 12.11.2 GSK Overview
    • 12.11.3 GSK Biological API Drug Manufacturing Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
    • 12.11.4 GSK Biological API Drug Manufacturing Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.11.5 GSK Recent Developments
  • 12.12 Pfizer CentreOne
    • 12.12.1 Pfizer CentreOne Company Information
    • 12.12.2 Pfizer CentreOne Overview
    • 12.12.3 Pfizer CentreOne Biological API Drug Manufacturing Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
    • 12.12.4 Pfizer CentreOne Biological API Drug Manufacturing Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.12.5 Pfizer CentreOne Recent Developments
  • 12.13 Sandoz
    • 12.13.1 Sandoz Company Information
    • 12.13.2 Sandoz Overview
    • 12.13.3 Sandoz Biological API Drug Manufacturing Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
    • 12.13.4 Sandoz Biological API Drug Manufacturing Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.13.5 Sandoz Recent Developments
  • 12.14 Vetter
    • 12.14.1 Vetter Company Information
    • 12.14.2 Vetter Overview
    • 12.14.3 Vetter Biological API Drug Manufacturing Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
    • 12.14.4 Vetter Biological API Drug Manufacturing Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.14.5 Vetter Recent Developments
  • 12.15 Wuxi Biologics
    • 12.15.1 Wuxi Biologics Company Information
    • 12.15.2 Wuxi Biologics Overview
    • 12.15.3 Wuxi Biologics Biological API Drug Manufacturing Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
    • 12.15.4 Wuxi Biologics Biological API Drug Manufacturing Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.15.5 Wuxi Biologics Recent Developments

13 Industry Chain and Sales Channels Analysis

  • 13.1 Biological API Drug Manufacturing Industry Chain Analysis
  • 13.2 Biological API Drug Manufacturing Key Raw Materials
    • 13.2.1 Key Raw Materials
    • 13.2.2 Raw Materials Key Suppliers
  • 13.3 Biological API Drug Manufacturing Production Mode & Process
  • 13.4 Biological API Drug Manufacturing Sales and Marketing
    • 13.4.1 Biological API Drug Manufacturing Sales Channels
    • 13.4.2 Biological API Drug Manufacturing Distributors
  • 13.5 Biological API Drug Manufacturing Customers

14 Biological API Drug Manufacturing Market Dynamics

  • 14.1 Biological API Drug Manufacturing Industry Trends
  • 14.2 Biological API Drug Manufacturing Market Drivers
  • 14.3 Biological API Drug Manufacturing Market Challenges
  • 14.4 Biological API Drug Manufacturing Market Restraints

15 Key Finding in The Global Biological API Drug Manufacturing Study

16 Appendix

  • 16.1 Research Methodology
    • 16.1.1 Methodology/Research Approach
    • 16.1.2 Data Source
  • 16.2 Author Details
  • 16.3 Disclaimer